MedTrace Logo

TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest

NCT02681224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2017-03-01

No results posted yet for this study

Summary

A single site, double-blind, randomized, placebo-controlled, clinical study comparing the difference between a novel healing gel and a placebo gel on post laser-resurfacing chests.

Conditions

  • Exposure Laser

Interventions

OTHER

TR987 Gel with Silon Bandage

Novel healing gel with occlusive dressing

OTHER

TR987 without Silon Bandage

Novel healing gel without occlusive dressing

OTHER

Placebo Gel with Silon Bandage

Placebo gel with occlusive dressing

OTHER

Placebo Gel without Silon Bandage

Placebo Gel without occlusive dressing

Sponsors & Collaborators

  • Goldman, Butterwick, Fitzpatrick and Groff

    lead OTHER

Principal Investigators

  • Mitchel P Goldman, MD · Cosmetic Laser Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-09-30
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02681224 on ClinicalTrials.gov